Incisive Surgical claims the staples, which are comprised of the same material as the bioabsorbable sutures, break down naturally, thereby eliminating the anxiety, pain, cost and inconvenience of post-operative staple removal.
The allowed claims include comprehensive subject matter covering the method and apparatus of the INSORB Skin Closure technology.
The company has received a notice of allowance of patent issuance from the USPTO relating to the absorbable staple.
In addition, the Japanese Patent Office issued a notice of allowance of patent issuance covering the method and apparatus of the INSORB Technology.
The company was issued a Japanese patent in 2010 relating to its absorbable staple.
Incisive Surgical president and CEO John Shannon said they have patents covering all three essential core elements of the INSORB Technology – the method, the absorbable staple, and the mechanical stapler.
